Document Detail


Primary cutaneous mucormycosis caused by Rhizomucor variabilis in an immunocompetent patient.
MedLine Citation:
PMID:  19562506     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Primary cutaneous mucormycosis is an uncommon disease and occurs mainly in patients with immunocompromised disorders. We report a case of cutaneous mucormycosis in an immunocompetent man in whom no definite precipitating factors were noted. The isolate was identified as Rhizomucor variabilis according to the fungus morphology and DNA sequencing results. The lesion was successfully treated with oral Itraconazole, although the in vitro drug-susceptibility test showed resistance.
Authors:
Ying Zhao; Qiangqiang Zhang; Li Li; Junhao Zhu; Kefei Kang; Lianjun Chen
Related Documents :
3170386 - Survival of staphylococcus epidermidis on the skin of patients of lepromatous leprosy.
6226496 - Incidence of common dermatoses in a predominantly black dermatologic practice.
20428906 - Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients.
2535016 - Drug eruptions (a series of 148 cases).
19473626 - Paricalcitol and outcome: a manual on how a vitamin d receptor activator (vdra) can hel...
23456496 - Cholecystectomy and clinical presentations of gastroparesis.
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2009-06-27
Journal Detail:
Title:  Mycopathologia     Volume:  168     ISSN:  1573-0832     ISO Abbreviation:  Mycopathologia     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-10-13     Completed Date:  2009-12-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7505689     Medline TA:  Mycopathologia     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  243-7     Citation Subset:  IM    
Affiliation:
Department of Dermatology, Huashan Hospital, Fudan University, 200040, Shanghai, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antifungal Agents / therapeutic use
Humans
Immunocompetence*
Itraconazole / therapeutic use
Male
Middle Aged
Mucormycosis / drug therapy,  microbiology*
Rhizomucor / physiology*
Chemical
Reg. No./Substance:
0/Antifungal Agents; 84625-61-6/Itraconazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Long-term neurodevelopmental effects of early detection and treatment in a 6-year-old patient with a...
Next Document:  Molecular cloning, sequence and expression analysis of ZmArf2, a maize ADP-ribosylation factor.